Key Players
Competitive Landscape
Competition in medication pouch rolls spans direct flexible healthcare packaging companies and adjacent pharmaceutical packaging specialists with different roles in material qualification. Nelipak Corporation and Amcor plc have documented flexible healthcare packaging and rollstock activity. Gerresheimer AG, West Pharmaceutical Services, Inc., SCHOTT Pharma, SGD Pharma and Aptar Pharma influence drug protection or compliance requirements through adjacent platforms. va-Q-tec Thermal Solutions GmbH and ThermoSafe contribute temperature-assurance expertise without representing core medication pouch roll revenue.
Healthcare packaging investment has recently moved toward regional manufacturing capacity and closer technical support for regulated customers. Nelipak completed its acquisition of Merrill’s Packaging in December 2025 and gained additional medical packaging operations in California and Costa Rica. Amcor inaugurated a new healthcare packaging production line in India during June 2026 to increase regional capacity and shorten response times. Packaging companies now compete on material qualification and service access in addition to web production scale.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| July 2025: Nelipak broke ground on a new healthcare packaging facility in Grecia, Costa Rica. | Medical and pharmaceutical customers require local cleanroom capacity and shorter package-development cycles. | Healthcare packaging companies are adding regulated regional production and development capacity closer to customers. | New regional capacity can support flexible packaging warehousing, validation work and contract growth in the Americas. |
| April 2025: SCHOTT Pharma opened a new glass ampoule manufacturing facility in Jagodina, Serbia. | Pharmaceutical manufacturers require dependable regional containment supply for injectable medicines and inspection-controlled production. | Drug-containment companies are expanding European manufacturing footprints as customers seek supply continuity and qualified capacity. | Adjacent containment investment raises qualification expectations that pouch-roll suppliers must meet for regulated pharmaceutical accounts. |
| May 2026: ThermoSafe expanded USA manufacturing of vacuum insulated panels for life-sciences cold-chain packaging. | Pharma shippers want greater supply assurance for temperature-sensitive medicines and shorter response times from packaging partners. | Temperature-assurance companies are bringing critical insulation production closer to pharmaceutical distribution customers. | Cold-chain projects create adjacent demand for documented thermal qualification and coordinated packaging support around sensitive therapies. |
| September 2025: Gerresheimer AG broke ground on a ready-to-fill vial production facility in Wertheim, Germany. | Biopharma customers need pre-sterilized containment formats that reduce fill-finish preparation while protecting sensitive drugs. | Pharmaceutical packaging investment is moving toward ready-to-fill formats and integrated qualification support for sensitive therapies. | Companies with documented validation and protection expertise can influence broader pharmaceutical packaging specifications near pouch-roll programs. |
West Pharmaceutical Services, Inc., SGD Pharma, Aptar Pharma, va-Q-tec Thermal Solutions GmbH and former Berry Global operations compete through adjacent containment, compliance, material or temperature-assurance capabilities.
Source: Future Market Insights, Medication Pouch Rolls Market Report, 2026-2036.
Together these companies cover flexible web production plus adjacent containment, validation and temperature-control requirements that influence how regulated pouch materials are qualified.
Who leads the medication pouch rolls market?
Public disclosures do not establish a medication pouch roll revenue ranking among the named companies. Nelipak Corporation and Amcor plc provide documented direct flexible healthcare packaging and rollstock evidence within this company set.
Which suppliers have documented qualification or quality approvals?
Nelipak Corporation and Amcor plc document regulated healthcare packaging quality systems while West Pharmaceutical Services, Inc. operates analytical testing and validation services. SGD Pharma also documents ISO 15378 certified manufacturing within its pharmaceutical glass network.
Which companies provide flexible healthcare packaging products?
Nelipak Corporation and Amcor plc document flexible healthcare packaging portfolios that include rollstock or web-based formats. Former Berry Global operations now participate through Amcor plc following the completed April 2025 combination.
Which suppliers serve North America and Western Europe?
Nelipak Corporation, Amcor plc, West Pharmaceutical Services, Inc., SCHOTT Pharma, Gerresheimer AG and ThermoSafe maintain operations or service coverage in both regions. Their participation ranges from flexible healthcare packaging to containment and temperature assurance.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| va-Q-tec Thermal Solutions GmbH | Adjacent pharmaceutical temperature-assurance specialist with reusable thermal transport systems. | September 2025: documented Swiss Post deployment of va-Q-tec thermal transport boxes for more than one million medicine deliveries. |
| Gerresheimer AG | Adjacent pharmaceutical containment and adherence platform serving prescription packaging and drug-delivery programs. | April 2025: Centor, a Gerresheimer company, launched a connected smart weekly pill organizer for USA pharmacies. |
| Nelipak Corporation | Direct flexible healthcare packaging company with rollstock plus sterile-barrier design and validation capabilities. | March 2026: opened an Asia-Pacific Technical Development Center in Singapore for flexible and rigid sterile-barrier packaging development. |
| West Pharmaceutical Services, Inc. | Adjacent pharmaceutical containment and testing company with contract packaging and validation services. | August 2025: opened a new analytical laboratory in Stolberg, Germany for release testing, method validation and microbiological work. |
| ThermoSafe | Adjacent temperature-assurance packaging company serving pharmaceutical and life-sciences distribution routes. | February 2026: launched Orion Express as a reusable temperature-controlled configuration for time-critical pharmaceutical shipments. |
| SCHOTT Pharma | Adjacent drug-containment company supplying glass and polymer systems for pharmaceutical filling and delivery. | August 2025: launched a ready-to-use polymer cartridge built to ISO dimensions for sensitive injectable medicines. |
| SGD Pharma | Adjacent pharmaceutical glass packaging company with oral and parenteral containment plus protection treatments. | October 2025: introduced Proseal+ external treatment for molded and tubular vials to improve moisture and oxygen protection. |
| Amcor plc | Direct healthcare flexible packaging company with rollstock manufacturing and medical-grade quality systems. | March 2026: its Winterbourne healthcare packaging site achieved ISO 13485:2016 certification. |
| Berry Global (integrated into Amcor plc since April 2025) | Legacy flexible packaging platform now operating within the combined Amcor corporate structure. | April 2025: Amcor plc completed its all-stock combination with Berry Global effective April 30. |
| Aptar Pharma | Adjacent pharmaceutical dosing and protection company with active materials and system-level development services. | July 2026: launched a system-level framework for injectable drug development with integrated testing and partner data packages. |
Research Methodology
The companies mapped here illustrate the medication pouch rolls market structure rather than an exhaustive ranking. Inclusion requires current verifiable evidence that a company supplies flexible healthcare packaging or an adjacent pharmaceutical packaging capability that materially affects pouch-roll qualification within the defined market scope. Evidence comes from regulatory approvals, third-party certifications, company announcements, product documentation and public filings. Capabilities are attributed to the stated flexible packaging, drug-containment, active-material, adherence-support or temperature-assurance platform rather than generalized across broader corporate portfolios. Market-share estimates remain proprietary FMI assessments for the forecast period.
